COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 552: Articles 5511-5520  | Next

No patient is the same; lessons learned from antibody repertoire profiling in hospitalized severe COVID-19 patients
Bondt, A., Hoek, M., Dingess, K., Tamara, S., de Graaf, B., Peng, W., den Boer, M. A., Damen, M., Zwart, C., Barendregt, A., van Rijswijck, D. M. H., Grobben, M., Tejjani, K., van Rijswijk, J., Voellmy, F. I., Snijder, J., Fortini, F., Papi, A., Volta, C. A., Campo, G., Contoli, M., van Gils, M. J., Spadaro, S., Rizzo, P., Heck, A. J. R.
10.1101/2022.12.23.22283896 — Posted: 2022-12-26
Omicron BA.5 infects human brain organoids and is neuroinvasive and lethal in K18-hACE2 mice
Stewart, R., Ellis, S. A., Yan, K., Dumenil, T., Tang, B., Nguyen, W., Bishop, C. R., Larcher, T., Parry, R., Sullivan, R. K. P., Lor, M., Khromykh, A. A., Meunier, F. A., Rawle, D. J., Suhrbier, A.
10.1101/2022.12.22.521696 — Posted: 2022-12-25
Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up.
Bramante, C. T., Buse, J. B., Liebovitz, D., Nicklas, J., Puskarich, M. A., Cohen, K., Belani, H., Anderson, B., Huling, J. D., Tignanelli, C., Thompson, J., Pullen, M., Siegel, L., Proper, J., Odde, D. J., Klatt, N., Sherwood, N., Lindberg, S., Wirtz, E. L., Krager, A., Beckman, K., Erickson, S., Fenno, S., Hartman, K., Rose, M., Patel, B., Griffiths, G., Bhat, N., Murray, T. A., Boulware, D. R.
10.1101/2022.12.21.22283753 — Posted: 2022-12-24
Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 Omicron sub-lineages
Touret, F., Giraud, E., Bourret, J., Donati, F., Tran-Rajau, J., Chiaravalli, J., Lemoine, F., Agou, F., Simon-Loriere, E., Van Der Werf, S., de Lamballerie, X.
10.1101/2022.12.22.521201 — Posted: 2022-12-23
Unbiased single cell spatial analysis localises inflammatory clusters of immature neutrophils-CD8 T cells to alveolar progenitor cells in fatal COVID-19 lungs
Weeratunga, P., Denney, L., Bull, J. A., Repapi, E., Sergeant, M., Etherington, R., Vuppusetty, C., Turner, G. D. H., Clelland, C., Cross, A., Issa, F., de Andrea, C. E., Bermejo, I. M., Sims, D., McGowan, S., Zurke, Y.-X., Ahern, D. J., Gamez, E. C., Whalley, J., Richards, D., Klenerman, P., Monaco, C., Udalova, I. A., Dong, T., Ogg, G., Knight, J., Byrne, H. M., Taylor, S., Ho, L.-P.
10.1101/2022.12.21.22283654 — Posted: 2022-12-23
Evaluation of Covid-19 antigen rapid diagnostic tests for self-testing in Lesotho and Zambia
Bresser, M., Erhardt, R. M., Shanaube, K., Simwinga, M., Mahlatsi, P. A., Belus, J., Schaap, A., Amstutz, A., Gachie, T., Glass, T. R., Kangolo, B., 'Mota, J., Floyd, S., Katende, B., Klinkenberg, E., Ayles, H., Reither, K., Ruperez, M.
10.1101/2022.12.21.22283827 — Posted: 2022-12-23
On the role of different age groups in propagating Omicron epidemics in France
Goldstein, E.
10.1101/2022.12.22.22283867 — Posted: 2022-12-23
Calculation and meaning of "excess mortality": A comparison of Covid- and pre-Covid mortality data in 31 Eurostat countries from 1965 to 2021.
Gill, B., Kehler, T., Schneider, M.
10.1101/2022.12.22.22283850 — Posted: 2022-12-23
Monkeypox Post COVID19: Knowledge, Worrying, and Vaccine Adoption of the Arabic General Population
Swed, S., Bohsas, H., Alibrahim, H., Rakab, A., Hafez, W., Sawaf, B., Amir Rais, M., Sallam Motawei, A., Aljabali, A., shoib, S., Atef Ismail Ahmed Ibrahim, I., Hussein Ahmad Almashaqbeh, S., Ahmed Qaid Shaddad, E., AlShaqsi, M., abdelrahman, A., fathey, S., Hurlemann, R., Elsayed, M., Padhi, B. K., Sah, R.
10.1101/2022.12.20.22283750 — Posted: 2022-12-23
Glyco-engineered pentameric SARS-CoV-2 IgMs show superior activities compared to IgG1 orthologues
Kallolimath, S., Palt, R., Föderl-Höbenreich, E., Sun, L., Chen, Q., Pruckner, F., Eidenberger, L., Strasser, R., Zatloukal, K., Steinkellner, H.
10.1101/2022.12.22.521646 — Posted: 2022-12-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).